Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Katayama, Hiroyuki"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-14 z 14
    Tytuł:
    Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor Prognosis.
    Autorzy:
    León-Letelier RA; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Abdel Sater AH; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Chen Y; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Park S; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Wu R; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Irajizad E; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Dennison JB; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Katayama H; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Vykoukal JV; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Hanash S; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Ostrin EJ; Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Fahrmann JF; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2023 Jan 29; Vol. 15 (3). Date of Electronic Publication: 2023 Jan 29.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Mining the Immunopeptidome for Antigenic Peptides in Cancer.
    Autorzy:
    León-Letelier RA; Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Katayama H; Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Hanash S; Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2022 Oct 11; Vol. 14 (20). Date of Electronic Publication: 2022 Oct 11.
    Typ publikacji:
    Journal Article; Review
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Novel UHRF1-MYC Axis in Acute Lymphoblastic Leukemia.
    Autorzy:
    Park S; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Sater AHA; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Fahrmann JF; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Irajizad E; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Cai Y; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Katayama H; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Vykoukal J; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Kobayashi M; Department of Basic Pathology, School of Medicine, Fukushima Medical University, Fukushima 960-1295, Japan.
    Dennison JB; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
    Gu Z; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
    Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Hanash S; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2022 Aug 31; Vol. 14 (17). Date of Electronic Publication: 2022 Aug 31.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune Response.
    Autorzy:
    Irajizad E; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Fahrmann JF; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Long JP; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Vykoukal J; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Kobayashi M; Department of Basic Pathology, School of Medicine, Fukushima Medical University, Hikarigaoka, Fukushima 960-1247, Japan.
    Capello M; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Yu CY; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Cai Y; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Hsiao FC; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Patel N; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Park S; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Peng Q; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Dennison JB; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Kato T; Department of Thoracic Surgery, Nagoya University, Nagoya 464-8601, Japan.
    Tai MC; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Taguchi A; Division of Molecular Diagnostics, Aichi Cancer Center, Nagoya 464-8601, Japan.; Division of Advanced Cancer Diagnostics, Nagoya University Graduate School of Medicine, Nagoya 464-8601, Japan.
    Kadara H; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Katayama H; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Do KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Hanash SM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Ostrin EJ; Departments of General Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Pokaż więcej
    Źródło:
    International journal of molecular sciences [Int J Mol Sci] 2022 Aug 11; Vol. 23 (16). Date of Electronic Publication: 2022 Aug 11.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Adenocarcinoma of Lung*/pathology
    Carcinoma, Non-Small-Cell Lung*/genetics
    Lung Neoplasms*
    Humans ; Immunity ; Proteins ; Proteomics/methods
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma.
    Autorzy:
    Fahrmann JF; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Tanaka I; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya 464-8601, Japan.
    Irajizad E; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Mao X; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Dennison JB; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Murage E; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Casabar J; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Mayo J; Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Peng Q; Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Celiktas M; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Vykoukal JV; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Park S; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Taguchi A; Division of Molecular Diagnostics, Aichi Cancer Center, Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan.
    Delgado O; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Tripathi SC; All India Institute of Medicine Sciences, Nagpur 441108, India.
    Katayama H; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Soto LMS; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Rodriguez-Canales J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Behrens C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Wistuba I; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Hanash S; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Ostrin EJ; Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2022 May 21; Vol. 14 (10). Date of Electronic Publication: 2022 May 21.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Plasma Based Protein Signatures Associated with Small Cell Lung Cancer.
    Autorzy:
    Fahrmann JF; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
    Katayama H; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
    Irajizad E; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
    Chakraborty A; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
    Kato T; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
    Mao X; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
    Park S; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
    Murage E; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
    Rusling L; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
    Yu CY; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
    Cai Y; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
    Hsiao FC; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
    Dennison JB; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
    Tran H; Department of Thoracic-Head & Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
    Ostrin E; Department of Pulmonary Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
    Wilson DO; Division of Pulmonary, Allergy and Critical Care Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA.
    Yuan JM; Division of Cancer Control and Population Sciences, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15232, USA.; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.
    Vykoukal J; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
    Hanash S; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2021 Aug 06; Vol. 13 (16). Date of Electronic Publication: 2021 Aug 06.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer.
    Autorzy:
    Dayde D; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Gunther J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Hirayama Y; Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
    Weksberg DC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; UPMC Pinnacle Radiation Oncology, Harrisburg, PA 17109, USA.
    Boutin A; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Parhy G; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Aguilar-Bonavides C; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Wang H; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Hangzhou Cosmos Wisdom Mass Spectrometry Center of Zhejiang University Medical School, Hangzhou 311200, China.
    Katayama H; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Abe Y; Division of Molecular Diagnostics, Aichi Cancer Center, Nagoya 464-8681, Japan.
    Do KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Hara K; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
    Kinoshita T; Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
    Komori K; Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
    Shimizu Y; Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
    Tajika M; Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
    Niwa Y; Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
    Wang YA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    DePinho R; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Hanash S; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Krishnan S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Radiation Oncology, Mayo Clinic Florida, Jacksonville, FL 32224, USA.
    Taguchi A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Division of Molecular Diagnostics, Aichi Cancer Center, Nagoya 464-8681, Japan.; Division of Advanced Cancer Diagnostics, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2021 Jul 20; Vol. 13 (14). Date of Electronic Publication: 2021 Jul 20.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Plasma-Derived Extracellular Vesicles Convey Protein Signatures that Reflect Pathophysiology in Lung and Pancreatic Adenocarcinomas.
    Autorzy:
    Fahrmann JF; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
    Mao X; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
    Irajizad E; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
    Katayama H; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
    Capello M; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
    Tanaka I; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan.
    Kato T; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
    Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
    Maitra A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
    Ostrin EJ; Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
    Hanash SM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; The McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
    Vykoukal J; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; The McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2020 May 02; Vol. 12 (5). Date of Electronic Publication: 2020 May 02.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients.
    Autorzy:
    Mandili G; Department of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Torino, Italy.; Center for Experimental Research and Medical Studies (CeRMS), University of Turin, 10126 Torino, Italy.
    Follia L; Department of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Torino, Italy.; Center for Experimental Research and Medical Studies (CeRMS), University of Turin, 10126 Torino, Italy.; Department of Computer Science, University of Turin, 10149 Torino, Italy.
    Ferrero G; Department of Computer Science, University of Turin, 10149 Torino, Italy.; Department of Clinical and Biological Sciences, San Luigi Hospital, University of Turin, 10043 Orbassano, Turin, Italy.
    Katayama H; MD Anderson Cancer Center, University of Texas, Houston, TX 77030, USA.
    Hong W; MD Anderson Cancer Center, University of Texas, Houston, TX 77030, USA.
    Momin AA; MD Anderson Cancer Center, University of Texas, Houston, TX 77030, USA.
    Capello M; MD Anderson Cancer Center, University of Texas, Houston, TX 77030, USA.
    Giordano D; Center for Experimental Research and Medical Studies (CeRMS), University of Turin, 10126 Torino, Italy.
    Spadi R; Centro Oncologico Ematologico Subalpino (COES), University of Turin, 10126 Torino, Italy.
    Satolli MA; Centro Oncologico Ematologico Subalpino (COES), University of Turin, 10126 Torino, Italy.
    Evangelista A; Cittá della salute e della scienza University Hospital of Turin, University of Turin, 10126 Torino, Italy.
    Hanash SM; MD Anderson Cancer Center, University of Texas, Houston, TX 77030, USA.
    Cordero F; Department of Computer Science, University of Turin, 10149 Torino, Italy.
    Novelli F; Department of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Torino, Italy.; Center for Experimental Research and Medical Studies (CeRMS), University of Turin, 10126 Torino, Italy.; Cittá della salute e della scienza University Hospital of Turin, University of Turin, 10126 Torino, Italy.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2020 Mar 21; Vol. 12 (3). Date of Electronic Publication: 2020 Mar 21.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Proteome Profiling Uncovers an Autoimmune Response Signature That Reflects Ovarian Cancer Pathogenesis.
    Autorzy:
    Kobayashi M; Department of Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
    Katayama H; Department of Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
    Irajizad E; Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
    Vykoukal JV; Department of Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
    Fahrmann JF; Department of Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
    Kundnani DL; Department of Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
    Yu CY; Department of Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
    Cai Y; Department of Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
    Hsiao FC; Department of Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
    Yang WL; Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
    Lu Z; Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
    Celestino J; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
    Long JP; Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
    Do KA; Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
    Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
    Ladd JJ; Translational Research Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA.
    Urban N; Translational Research Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA.
    Bast RC Jr; Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
    Hanash SM; Department of Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2020 Feb 19; Vol. 12 (2). Date of Electronic Publication: 2020 Feb 19.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Quantitative proteomic analysis of histone modifications in decitabine sensitive and resistant leukemia cell lines.
    Autorzy:
    Zhang C; Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, 6767 Bertner Ave, Houston, TX 77030 USA.
    Suo J; Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, 6767 Bertner Ave, Houston, TX 77030 USA.
    Katayama H; Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, 6767 Bertner Ave, Houston, TX 77030 USA.
    Wei Y; Department of Leukemia, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 428, Houston, TX 77030 USA.
    Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 428, Houston, TX 77030 USA.
    Hanash S; Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, 6767 Bertner Ave, Houston, TX 77030 USA.
    Pokaż więcej
    Źródło:
    Clinical proteomics [Clin Proteomics] 2016 Jul 05; Vol. 13, pp. 14. Date of Electronic Publication: 2016 Jul 05 (Print Publication: 2016).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    A mouse to human search for plasma proteome changes associated with pancreatic tumor development.
    Autorzy:
    Faca VM; Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    Song KS
    Wang H
    Zhang Q
    Krasnoselsky AL
    Newcomb LF
    Plentz RR
    Gurumurthy S
    Redston MS
    Pitteri SJ
    Pereira-Faca SR
    Ireton RC
    Katayama H
    Glukhova V
    Phanstiel D
    Brenner DE
    Anderson MA
    Misek D
    Scholler N
    Urban ND
    Barnett MJ
    Edelstein C
    Goodman GE
    Thornquist MD
    McIntosh MW
    DePinho RA
    Bardeesy N
    Hanash SM
    Pokaż więcej
    Źródło:
    PLoS medicine [PLoS Med] 2008 Jun 10; Vol. 5 (6), pp. e123.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Biomarkers, Tumor/*blood
    Pancreatic Neoplasms/*diagnosis
    Proteome/*metabolism
    Animals ; Humans ; Mass Spectrometry ; Mice ; Pancreatic Neoplasms/blood ; Proteomics/methods ; RNA, Messenger/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    IMS-free DNA extraction for the PCR-based quantification of Cryptosporidium parvum and Giardia lamblia in surface and waste water.
    Autorzy:
    Anceno AJ; Environmental Engineering and Management, Asian Institute of Technology, Pathumthani, Thailand.
    Katayama H
    Houpt ER
    Chavalitshewinkoon-Petmitr P
    Chuluun B
    Shipin OV
    Pokaż więcej
    Źródło:
    International journal of environmental health research [Int J Environ Health Res] 2007 Aug; Vol. 17 (4), pp. 297-310.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Cryptosporidium parvum/*isolation & purification
    DNA/*isolation & purification
    Environmental Monitoring/*methods
    Giardia lamblia/*isolation & purification
    Water/*parasitology
    Animals ; Cryptosporidium parvum/genetics ; DNA/classification ; Genotype ; Giardia lamblia/genetics ; Immunomagnetic Separation ; Polymerase Chain Reaction/methods
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Attractive axon guidance involves asymmetric membrane transport and exocytosis in the growth cone.
    Autorzy:
    Tojima T; Laboratory for Neuronal Growth Mechanisms, Brain Science Institute, The Institute of Physical and Chemical Research (RIKEN), 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
    Akiyama H
    Itofusa R
    Li Y
    Katayama H
    Miyawaki A
    Kamiguchi H
    Pokaż więcej
    Źródło:
    Nature neuroscience [Nat Neurosci] 2007 Jan; Vol. 10 (1), pp. 58-66. Date of Electronic Publication: 2006 Dec 10.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Axons/*physiology
    Exocytosis/*physiology
    Growth Cones/*physiology
    Neurons/*cytology
    Animals ; Antineoplastic Agents/pharmacology ; Axons/drug effects ; Biological Transport/drug effects ; Biological Transport/physiology ; Calcium/metabolism ; Calcium/pharmacology ; Cells, Cultured ; Chelating Agents/pharmacology ; Chick Embryo ; Cyclic AMP/analogs & derivatives ; Cyclic AMP/pharmacology ; Drug Interactions ; Egtazic Acid/analogs & derivatives ; Egtazic Acid/pharmacology ; Exocytosis/drug effects ; Ganglia, Spinal/cytology ; Green Fluorescent Proteins/metabolism ; Growth Cones/drug effects ; Metalloendopeptidases/pharmacology ; Nocodazole/pharmacology ; Photolysis/drug effects ; Protein Kinase Inhibitors/pharmacology ; Pyridinium Compounds ; Quaternary Ammonium Compounds ; Tetanus Toxin/pharmacology ; Thionucleotides/pharmacology ; Transfection/methods ; Vesicle-Associated Membrane Protein 2/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-14 z 14

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies